142 related articles for article (PubMed ID: 17880765)
1. Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy.
Falasca K; Ucciferri C; Manzoli L; Mancino P; Pizzigallo E; Conti P; Vecchiet J
Int J Immunopathol Pharmacol; 2007; 20(3):519-27. PubMed ID: 17880765
[TBL] [Abstract][Full Text] [Related]
2. Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy.
Vigouroux C; Maachi M; Nguyên TH; Coussieu C; Gharakhanian S; Funahashi T; Matsuzawa Y; Shimomura I; Rozenbaum W; Capeau J; Bastard JP
AIDS; 2003 Jul; 17(10):1503-11. PubMed ID: 12824788
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.
Jantarapakde J; Phanuphak N; Chaturawit C; Pengnonyang S; Mathajittiphan P; Takamtha P; Dungjun N; Pinyakorn S; Pima W; Prasithsirikul W; Phanuphak P
AIDS Patient Care STDS; 2014 Jul; 28(7):331-40. PubMed ID: 24914459
[TBL] [Abstract][Full Text] [Related]
4. Burden of metabolic syndrome among HIV-infected patients in Southern Ethiopia.
Tesfaye DY; Kinde S; Medhin G; Megerssa YC; Tadewos A; Tadesse E; Shimelis T
Diabetes Metab Syndr; 2014; 8(2):102-7. PubMed ID: 24907175
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease.
Guaraldi G; Ventura P; Garlassi E; Orlando G; Squillace N; Nardini G; Stentarelli C; Zona S; Marchini S; Moriondo V; Tebas P
HIV Med; 2009 Jan; 10(1):28-34. PubMed ID: 19125962
[TBL] [Abstract][Full Text] [Related]
6. What should we know about metabolic syndrome and lipodystrophy in AIDS?
Signorini DJ; Monteiro MC; Andrade Mde F; Signorini DH; Eyer-Silva Wde A
Rev Assoc Med Bras (1992); 2012; 58(1):70-5. PubMed ID: 22392319
[TBL] [Abstract][Full Text] [Related]
7. The metabolic syndrome, an epidemic among HIV-infected patients on HAART.
Jevtović DJ; Dragović G; Salemović D; Ranin J; Djurković-Djaković O
Biomed Pharmacother; 2009 Jun; 63(5):337-42. PubMed ID: 18996676
[TBL] [Abstract][Full Text] [Related]
8. Liver triglyceride content in HIV-1-infected patients on combination antiretroviral therapy studied with 1H-MR spectroscopy.
Moreno-Torres A; Domingo P; Pujol J; Blanco-Vaca F; Arroyo JA; Sambeat MA
Antivir Ther; 2007; 12(2):195-203. PubMed ID: 17503662
[TBL] [Abstract][Full Text] [Related]
9. Association of inflammatory cytokines and endothelial adhesion molecules with immunological, virological, and cardiometabolic disease in HIV-infected individuals.
Lacerda HR; Falcão Mda C; de Albuquerque VM; Zírpoli JC; Miranda-Filho Dde B; de Albuquerque Mde F; Montarroyos U; Ximenes RA
J Interferon Cytokine Res; 2014 May; 34(5):385-93. PubMed ID: 24359573
[TBL] [Abstract][Full Text] [Related]
10. Features of Metabolic Syndrome and Its Associated Factors during Highly Active Antiretroviral Therapy in Ouagadougou (Burkina Faso).
Guira O; Tiéno H; Diendéré AE; Sagna Y; Diallo I; Yaméogo B; Zoungrana L; Yaméogo TM; Bognounou R; Drabo JY
J Int Assoc Provid AIDS Care; 2016; 15(2):159-63. PubMed ID: 26307211
[TBL] [Abstract][Full Text] [Related]
11. Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy.
Estrada V; Martínez-Larrad MT; González-Sánchez JL; de Villar NG; Zabena C; Fernández C; Serrano-Ríos M
Metabolism; 2006 Jul; 55(7):940-5. PubMed ID: 16784968
[TBL] [Abstract][Full Text] [Related]
12. [Abnormal body fat distribution and type of antiretroviral therapy as predictors of cardiovascular disease risk in HIV-infected patients].
Ena J; Benito C; Llácer P; Pasquau F; Amador C
Med Clin (Barc); 2004 May; 122(19):721-6. PubMed ID: 15171905
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS).
Viladés C; Escoté X; López-Dupla M; Martinez E; Domingo P; Asensi V; Leal M; Peraire J; Inza MI; Arnedo M; Gutiérrez M; Valle-Garay E; Ferrando-Martinez S; Olona M; Alba V; Sirvent JJ; Gatell JM; Vidal F;
J Antimicrob Chemother; 2014 Jun; 69(6):1653-9. PubMed ID: 24535275
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
[TBL] [Abstract][Full Text] [Related]
15. Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients.
Badiou S; Thiebaut R; Aurillac-Lavignolle V; Dabis F; Laporte F; Cristol JP; Mercie P;
J Infect; 2008 Jul; 57(1):47-54. PubMed ID: 18554723
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population.
Mondy K; Overton ET; Grubb J; Tong S; Seyfried W; Powderly W; Yarasheski K
Clin Infect Dis; 2007 Mar; 44(5):726-34. PubMed ID: 17278068
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America.
Alvarez C; Salazar R; Galindez J; Rangel F; Castaãeda ML; Lopardo G; Cuhna CA; Roldan Y; Sussman O; Gutierrez G; Cure-Bolt N; Seas C; Carcamo C; Castrillo M
Braz J Infect Dis; 2010; 14(3):256-63. PubMed ID: 20835509
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
Feleke Y; Fekade D; Mezegebu Y
Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
[TBL] [Abstract][Full Text] [Related]
19. Independent predictors of metabolic syndrome in HIV-infected patients.
Alencastro PR; Fuchs SC; Wolff FH; Ikeda ML; Brandão AB; Barcellos NT
AIDS Patient Care STDS; 2011 Nov; 25(11):627-34. PubMed ID: 21936688
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome in French HIV-infected patients: prevalence and predictive factors after 3 years of antiretroviral therapy.
Biron A; Bobin-Dubigeon C; Volteau C; Piroth L; Perré P; Leport C; Prazuck T; Jovelin T; Billard M; Sébille V; Bard JM; Raffi F; Biron C
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1672-8. PubMed ID: 22731114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
